Increased risk: means risk exceeding the risk typically experienced by an individual who is not using, and is not likely to use, an opiate. See Utah Code 26B-4-501
Opiate antagonist: means naloxone hydrochloride or any similarly acting drug that is not a controlled substance and that is approved by the federal Food and Drug Administration for the diagnosis or treatment of an opiate-related drug overdose. See Utah Code 26B-4-501
Opiate-related drug overdose event: means an acute condition, including a decreased level of consciousness or respiratory depression resulting from the consumption or use of a controlled substance, or another substance with which a controlled substance was combined, and that a person would reasonably believe to require medical assistance. See Utah Code 26B-4-501
Overdose outreach provider: means :
(a)
a law enforcement agency;
(b)
a fire department;
(c)
an emergency medical service provider, as defined in Section 26B-4-101;
(d)
emergency medical service personnel, as defined in Section 26B-4-101;
(e)
an organization providing treatment or recovery services for drug or alcohol use;
(f)
an organization providing support services for an individual, or a family of an individual, with a substance use disorder;
(g)
an organization providing substance use or mental health services under contract with a local substance abuse authority, as defined in Section 26B-5-101, or a local mental health authority, as defined in Section 26B-5-101;
(h)
an organization providing services to the homeless;
pursuant to a standing prescription drug order made in accordance with Subsection (2); and
(b)
without any other prescription drug order from a person licensed to prescribe an opiate antagonist.
(2)
A physician who is licensed to prescribe an opiate antagonist, including a physician acting in the physician’s capacity as an employee of the department, or a medical director of a local health department, as defined in Section 26B-4-512, may issue a standing prescription drug order authorizing the dispensing of the opiate antagonist under Subsection (1) in accordance with a protocol that:
(a)
limits dispensing of the opiate antagonist to:
(i)
an individual who is at increased risk of experiencing an opiate-related drug overdose event;
(ii)
a family member of, friend of, or other person, including a person described in Subsections 26B-4-512(1)(a)(i)(A) through (1)(a)(i)(F), that is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; or
(iii)
an overdose outreach provider for:
(A)
furnishing to an individual who is at increased risk of experiencing an opiate-related drug overdose event, or to a family member of, friend of, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event, as provided in Section 26B-4-511; or
(B)
administering to an individual experiencing an opiate-related drug overdose event;
(b)
requires the physician to specify the persons, by professional license number, authorized to dispense the opiate antagonist;
(c)
requires the physician to review at least annually the dispensing practices of those authorized by the physician to dispense the opiate antagonist;
(d)
requires those authorized by the physician to dispense the opiate antagonist to make and retain a record of each person to whom the opiate antagonist is dispensed, which shall include:
